Desteghe Lien, Engelhard Lara, Raymaekers Zina, Kluts Kiki, Vijgen Johan, Dilling-Boer Dagmara, Koopman Pieter, Schurmans Joris, Dendale Paul, Heidbuchel Hein
Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium; Heart Centre Hasselt, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.
Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium.
Int J Cardiol. 2016 Nov 15;223:906-914. doi: 10.1016/j.ijcard.2016.08.303. Epub 2016 Aug 21.
The aim of this study was to develop and validate a new questionnaire, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ), to test the knowledge of patients with atrial fibrillation (AF) about the arrhythmia, its treatment and their ability for self-management.
The JAKQ was developed based on other questionnaires, two educational checklists and patient information support websites. The JAKQ was validated based on content validity, face validity, response process, discriminatory potential and sensitivity of the questionnaire, construct validity and reliability. It was presented to both outpatients and hospitalised patients.
A total of 466 AF patients completed the JAKQ. The final 16-item JAKQ consists of 8 questions about AF in general, 5 questions about oral anticoagulation (OAC) therapy and either 3 questions about vitamin K antagonists (VKA) or non-vitamin K antagonist oral anticoagulants (NOAC). The questionnaire is completed in 6.5±2.4min. The mean score on the JAKQ is 55.8±18.6% with a wide discriminatory span of scores. The JAKQ reveals important knowledge gaps, like 28.8% of the patients not being aware of their medical condition named 'atrial fibrillation', 33.7% being unaware that AF can cause thromboembolism and stroke, and 78.6% of the patients taking VKA and 57.0% of the patients on NOACs not knowing what to do when missing an OAC dose.
The JAKQ is a brief, complete and valid AF-specific knowledge questionnaire that can be used in daily practice to assess patients' insight into their condition. It could be used as a tool for individually tailored patient education.
本研究旨在开发并验证一份新的问卷——杰萨房颤知识问卷(JAKQ),以测试房颤(AF)患者对心律失常及其治疗的了解程度以及自我管理能力。
JAKQ是在其他问卷、两份教育清单和患者信息支持网站的基础上开发的。通过内容效度、表面效度、应答过程、问卷的区分潜力和敏感性、结构效度及信度对JAKQ进行验证。该问卷面向门诊患者和住院患者发放。
共有466例房颤患者完成了JAKQ。最终的16项JAKQ包括8个关于房颤总体情况的问题、5个关于口服抗凝药(OAC)治疗的问题以及3个关于维生素K拮抗剂(VKA)或非维生素K拮抗剂口服抗凝药(NOAC)的问题。问卷完成时间为6.5±2.4分钟。JAKQ的平均得分为55.8±18.6%,得分区间差异较大。JAKQ揭示了一些重要的知识空白,比如28.8%的患者不知道自己患有“房颤”,33.7%的患者不知道房颤会导致血栓栓塞和中风,78.6%服用VKA的患者以及57.0%服用NOAC的患者不知道漏服一剂OAC时该怎么办。
JAKQ是一份简短、完整且有效的房颤特异性知识问卷,可用于日常实践中评估患者对自身病情的了解程度。它可作为个性化患者教育的工具。